Clik here to view.
Valeritas touts positive results for V-Go wearable insulin delivery device
Valeritas (NSDQ:VLRX) shares jumped this morning after the company touted positive results from its Enable study, showing that patients who switched from insulin pens and syringes to the company’s...
View ArticleClik here to view.
Closed-loop insulin delivery systems shine at annual diabetes meeting
As device-makers, healthcare practitioners and people with diabetes convened at this year’s annual meeting of the American Diabetes Association, one major theme emerged: the industry is catching on to...
View ArticleClik here to view.
Senseonics prices $130m public offering
On the heels of an FDA approval for its implantable continuous glucose monitoring tech, Senseonics‘ (NYSE:SENS) today priced a $130 million underwritten public offering of common stock. The offering,...
View ArticleClik here to view.
Sensile Medical partners with Verily, Sanofi to develop connected insulin...
Swiss medical device-maker Sensile Medical announced this week that it struck a deal with Verily and Sanofi (NYSE:SNY) to develop and commercialize a connected insulin patch pump. The pre-filled...
View ArticleClik here to view.
Eli Lilly touts data for concentrated insulin delivered via Insulet’s Omnipod...
Eli Lilly (NYSE:LLY) touted data this week from a Phase III study evaluating its Humulin R U-500 concentrated insulin delivered via Insulet‘s (NSDQ:PODD) investigational Omnipod U-500 device. The...
View ArticleClik here to view.
Study: Heat-stable drug formulation offers new option to prevent postpartum...
Data from a collaboration between Ferring Pharmaceuticals, Merck (NYSE:MRK) and the World Health Organization showed that a heat-stable formulation of carbetocin is as effective as oxytocin for the...
View ArticleClik here to view.
Medtronic launches outcomes-based reimbursement program for MiniMed 670G system
Medtronic (NYSE:MDT) today launched an outcomes-based reimbursement program for its MiniMed 670G automated insulin delivery system. As part of its ‘MiniMed 670G Performance Guarantee Program,’ the...
View ArticleClik here to view.
Novartis to spin out Alcon ophthalmic subsidiary
Novartis (NYSE:NVS) said today that it’s planning to spin its Alcon ophthalmology subsidiary into a publicly traded company after years of speculation that it wanted to sell the ill-starred division....
View ArticleClik here to view.
Sage Therapeutics’ chief scientist on discovering drugs and taking risks
When Al Robichaud got his start as a medicinal chemist in 1991, he knew that discovering and developing drugs meant shouldering some level of risk. But around 2011, it became clear that the process for...
View ArticleClik here to view.
Ocular Therapeutix resubmits NDA for ocular pain relief implant
Ocular Therapeutix (NSDQ:OCUL) said today that it resubmitted a new drug application for its Dextenza ocular pain relief implant to the FDA. The Bedford, Mass.-based company noted that the resubmitted...
View ArticleClik here to view.
Ocugen launches Ph3 trial for eye disease nanoemulsion
Ocugen said today that it launched the first of two pivotal Phase III trials for its OCU300 nanoemulsion designed to treat the symptoms of ocular graft versus host disease. The Malvern, Penn.-based...
View ArticleClik here to view.
Novartis steps in to compete with Mylan’s Epipen
Adamis Pharmaceuticals (NSDQ:ADMP) said this week that it inked an exclusive deal with Novartis‘ (NYSE:NVS) Sandoz unit to distribute and commercialize its Symjepi emergency allergy treatment. The...
View ArticleClik here to view.
Insulet assumes direct commercial operations in Europe
Insulet (NSDQ:PODD) said today that it has assumed direct commercial operations in Europe for its Omnipod tubeless insulin pump. The Billerica, Mass.-based company first announced it would part ways...
View ArticleClik here to view.
Insulet’s Omnipod nabs preferred insulin pump status in British Columbia
Insulet (NSDQ:PODD) said today that its Omnipod device was selected as the preferred insulin pump in British Columbia, Canada under the province’s expanded PharmaCare insulin pump program. According to...
View ArticleClik here to view.
Catalent expands early-phase development skills with $139m Juniper buyout
Catalent (NYSE:CTLT) said today that it inked a $139 million deal to acquire Juniper Pharmaceuticals (NSDQ:JNPR) and its early-stage product development services. The company noted that its Juniper...
View ArticleClik here to view.
Siga Technologies touts pivotal data for oral smallpox therapy
Siga Technologies (NSDQ:SIGA) said today that data from a pivotal human safety study and animal efficacy studies of its oral smallpox therapy were published in the New England Journal of Medicine. Data...
View ArticleClik here to view.
Drug-coated balloon developer Urotronic raises $6m
Urotronic has raised $6.1 million in an equity offering involving 21 investors, according to a document filed with the SEC this week. The Minnesota-based company has not publicly stated how it plans to...
View ArticleClik here to view.
Vaccine maker PaxVax tackles the unmet need posed by chikungunya virus
Transmitted by the same mosquitoes that spread Zika virus and dengue fever, the chikungunya virus is named for an African word meaning “to become contorted.” People infected with the alphavirus are...
View ArticleClik here to view.
Companion Medical wins FDA nod for Android version of smart pen app
Companion Medical said today that it won FDA clearance for the Android version of its InPen app. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated...
View ArticleClik here to view.
Mylan launches generic drug-delivery patch for dementia patients
Mylan (NSDQ:MYL) announced today the U.S. launch of its rivastigmine transdermal drug-delivery patch, a generic version of Novartis‘ (NYSE:NVS) Exelon therapy. The company’s rivastigmine therapy is...
View Article